Filing Details

Accession Number:
0001562180-21-002916
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-22 21:20:51
Reporting Period:
2021-04-21
Accepted Time:
2021-04-22 21:20:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1404123 1Life Healthcare Inc ONEM Services-Offices & Clinics Of Doctors Of Medicine (8011) 760707204
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800512 D Kimber Lockhart C/O 1Life Healthcare, Inc.
One Embarcadero Center, Suite 1900
San Francisco CA 94111
Chief Technology Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-21 729 $4.36 71,163 No 4 M Direct
Common Stock Acquisiton 2021-04-21 29,271 $11.56 100,434 No 4 M Direct
Common Stock Disposition 2021-04-21 30,000 $41.39 70,434 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-04-21 729 $0.00 729 $4.36
Common Stock Stock Option (Right to Buy) Disposition 2021-04-21 29,271 $0.00 29,271 $11.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
95,852 2028-02-14 No 4 M Direct
249,468 2029-11-20 No 4 M Direct
Footnotes
  1. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to reporting person's continuous service as of each such date.
  2. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to reporting person's continuous service as of each such date.
  3. These trades were made pursuant to a Rule 10b5-1 trading plan with shares of common stock received upon concurrent exercises of stock options.
  4. This transaction was executed in multiple trades at prices ranging from $40.99 to $41.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.